This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Mondor's Disease

KENNETH B. CASTLETON, MD; R. SIDNEY CLOUD, MD; JOHN R. WARD, MD

AMA Arch Surg. 1964;88(6):1010-1012.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1939 Mondor¹ described the clinical and pathological features of a benign, selflimited phlebitis and periphlebitis of superficial veins on the anterior chest wall. He originally used the term "angeitis" and later identified the pathology as a thrombophlebitis,² confirming the clinical impression of Shields,³ Fiessinger and Mathieu,⁴ and Daniels.⁵ Since Mondor's original paper the eponym, Mondor's disease, has been used commonly.

Although there are fewer than 200 cases reported, Mondor's disease is probably of common clinical occurrence. Farrow⁶ reported 43 patients, of whom 18 were seen in one year, and Adair⁷ saw 26 patients with the disease in eight years. The clinical features are clearly diagnostic. The occurrence of pain and the presence of a tender, subcutaneous linear cord in the distribution of the superficial veins of the anterolateral chest wall or upper abdomen make the diagnosis. The presence of cellulitis, abscesses, or . . . [Full Text PDF of this Article]

Author Affiliations
SALT LAKE CITY

Dean (Dr. Castleton); Research Fellow, Division of Arthritis (Dr. Cloud); Associate Professor of Medicine and Chief, Division of Arthritis, Department of Internal Medicine (Dr. Ward); University of Utah College of Medicine.; From the departments of surgery and medicine, University of Utah College of Medicine, and the Salt Lake County General Hospital.

Footnotes
Submitted for publication Jan 14, 1964.

Supported in part by grant T1 AM 5016-08 and 08S1, National Institute of Arthritis and Metabolic Diseases, United States Public Health Service, Department of Health, Education, and Welfare, Bethesda, Md.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?